Best evidence topic reports (BETs) summarise the evidence pertaining to particular clinical questions. They are not systematic reviews, but rather contain the best (highest level) evidence that can be practically obtained by busy practising clinicians. The search strategies used to find the best evidence are reported in detail in order to allow clinicians to update searches whenever necessary.
The BETs published below were first reported at the Critical Appraisal Journal Club at the Manchester Royal Infirmary. 1 Each BET has been constructed in the four stages that have been described elsewhere. 2 The BETs shown here together with those published previously and those currently under construction can be seen at http:// www.bestbets.org. 3 Eight topics are covered in this issue of the journal 
Lorazepam or diazepam for generalised convulsions in adults

Comments
There are five randomised trials that address the three part question. All of the studies are of reasonable quality.
Clinical bottom line
Initial treatment can be either salbutamol or ipratropium nebulisers alone. There is no evidence to suggest that using both has additional benefit. 
Comments
This study shows that there are no significant clinical diVerences between the two treatments. In such a case the relative cost of the treatment is an important factor in deciding which should be prescribed. 
Clinical bottom line
Nebulised epinephrine and nebulised budesonide are as eVective as each other in moderately severe croup.
Prophylactic magnesium in myocardial infarction
Comments
A number of small studies published have suggested that magnesium therapy significantly improves mortality following myocardial infarction. While the two larger studies show a trend to reduction in the incidence of ventricular fibrillation but also demonstrates that this benefit is outweighed by an increased incidence of detrimental eVects.
Clinical bottom line
Routine prophylactic magnesium in patients with myocardial infarction is not indicated. 
Search outcome
Altogether 741 and 37 papers found of which 13 were relevant and of suYcient quality. These 13 remaining papers are shown in table  6 .
Comments
The "gold standard" investigation for DVT is contrast venography. This has now been replaced in many centres with a strategy of single or serial compression ultrasound, hence the use of diVerent reference standard tests. If an investigation is to be used in order to rule out a diagnosis, then it must have a sensitivity of 95% or above. In some of the studies mentioned this is the case, however such is the variability of the results obtained in the other studies the safety of SimpliRed as a lone exclusionary test must be in question. The reasons for this variability may include the operators of the assay or the various techniques used. Many of the results however are still inadequate.
Clinical bottom line
It is not safe to use SimpliRed as a lone exclusionary test for a patient presenting to the emergency department with a possible DVT. 
Comments
There is some laboratory evidence that biphasic defibrillation has higher first shock success rates for defibrillation of VF/VT. A theoretical advantage exists with biphasic devices but there is no clinical evidence of increased survival in cardiac arrest occurring outside the cardiac arrhythmia laboratory.
Clinical bottom line
The advantages of biphasic devices are currently mainly theoretical. No real world data exist that would suggest an immediate conversion to using biphasic devices. 
Comments
Most cases of otitis media will spontaneously resolve.
Clinical bottom line
There is some benefit from the use of antibiotics in otitis media. 
